Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bodhi Tree Biotechnology (BDTB) Cash & Equivalents (2024 - 2025)

Historic Cash & Equivalents for Bodhi Tree Biotechnology (BDTB) over the last 2 years, with Q4 2025 value amounting to $47366.0.

  • Bodhi Tree Biotechnology's Cash & Equivalents fell 7562.14% to $47366.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $47366.0, marking a year-over-year decrease of 7562.14%. This contributed to the annual value of $109404.0 for FY2025, which is N/A changed from last year.
  • As of Q4 2025, Bodhi Tree Biotechnology's Cash & Equivalents stood at $47366.0, which was down 7562.14% from $109404.0 recorded in Q3 2025.
  • Bodhi Tree Biotechnology's Cash & Equivalents' 5-year high stood at $194293.0 during Q4 2024, with a 5-year trough of $47366.0 in Q4 2025.